Results 51 to 60 of about 47,470 (259)

Role of preoperative Hounsfield units in predicting subsidence after anterior cervical discectomy and fusion in the United States: a retrospective analysis including osteopenia diagnosis [PDF]

Asian Spine Journal
Study Design A retrospective cohort study. Purpose This study aimed to investigate the relationship among osteopenia, bone density, and subsidence following anterior cervical discectomy and fusion (ACDF).
Wasil Ahmed, Akiro Duey, Rami Rajjoub, Timothy Hoang, Bashar Zaidat, Zachary Milestone, Jiwoo Park, Christopher Gonzalez, Pierce Ferriter, Junho Song Jun, Kim Samuel Cho   +10 more
doaj   +1 more source

Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma

Scientific Reports, 2022
Osteopenia is known to be associated with clinical frailty which is linked to inferior outcomes in various clinical scenarios. However, the exact prognostic value of osteopenia in patients undergoing curative intent-surgery for hepatocellular carcinoma ...
Franziska Alexandra Meister, Suekran Verhoeven, Anna Mantas, Wen-Jia Liu, Decan Jiang, Lara Heij, Daniel Heise, Philipp Bruners, Sven Arke Lang, Tom Florian Ulmer, Ulf Peter Neumann, Jan Bednarsch, Zoltan Czigany   +12 more
doaj   +1 more source

Extracellular vesicles rejuvenate the microenvironmental modulating function of recipient tissue-specific mesenchymal stem cells in osteopenia treatment

Frontiers in Endocrinology, 2023
Systemic transplantation of mesenchymal stem cells (MSCs), such as bone marrow MSCs (BMMSCs) and stem cells from human exfoliated deciduous teeth (SHED), is considered a prominent treatment for osteopenia.
Soichiro Sonoda, Takayoshi Yamaza
doaj   +1 more source

Osteopenia - sorting out the confusion

, 2006
Osteoporosis is a bone disorder characterised by low bone mass and an increase in bone fragility and susceptibility to fracture. Diagnostic categories of osteoporosis and osteopenia (a less severe form of osteoporosis) have been defined on the basis of ...
DA Davey, Davey, DA
core   +1 more source

Mind the gap: Adherence to denosumab dosing and cessation guidelines in Australian residential aged care

British Journal of Clinical Pharmacology, EarlyView.
This original research used medication administration data to explore adherence to treatment guidelines for the most common osteoporosis medications in long‐term residential aged care (RAC) in Australia. The paper highlights gaps in adherence to treatment guidelines that must be addressed to improve outcomes of older adults living in RAC.
Marea O'Donnell, Johanna I. Westbrook, Bayzidur Rahman, Isabelle Meulenbroeks, Nasir Wabe, Ian D. Cameron, Mark Morgan, Magdalena Z. Raban   +7 more
wiley   +1 more source

Treatment of osteopenia and osteoporosis

, 2021
The invention provides an agent for modulating the activity of CLEC14A for the use in treating and/or preventing osteopenia and/or ...
Naylor, Amy; id_orcid, Bicknell, Roy
core  

Table_2_Association between osteoporosis or osteopenia and taking antiplatelet agents in general US population of NHANES.xlsx

, 2022
BackgroundOsteoporosis (OP) and osteopenia are common bone disorders in old age, and lots of patients suffering from OP or osteopenia need to take antiplatelet agents to treat basic diseases.
Hao Lv (740606), Mingzhu Qiao (13220364), Jiuxiang Wang (12125238), Ting Jiang (792240), Yujun Zhu (4016534), Ziwen Wang (106246), Zhimu Hu (13220361)   +6 more
core   +1 more source

Management of severe bone loss in patients at risk of medication‐related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study

Clinical Advances in Periodontics, EarlyView.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira, José Maurício Paradella de Camargo, Lara Maria Alencar Ramos Innocentini, Ana Carolina Fragoso Motta   +3 more
wiley   +1 more source

Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?

Clinical Pharmacology &Therapeutics, EarlyView.
Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu, Renn‐Chia Lin, Ing‐Lin Chang, Shau‐Huai Fu, Meng‐Ying Tsai, Shun‐Fa Yang   +5 more
wiley   +1 more source

DataSheet_1_Association between osteoporosis or osteopenia and taking antiplatelet agents in general US population of NHANES.csv

, 2022
BackgroundOsteoporosis (OP) and osteopenia are common bone disorders in old age, and lots of patients suffering from OP or osteopenia need to take antiplatelet agents to treat basic diseases.
Hao Lv (740606), Mingzhu Qiao (13220364), Jiuxiang Wang (12125238), Ting Jiang (792240), Yujun Zhu (4016534), Ziwen Wang (106246), Zhimu Hu (13220361)   +6 more
core   +1 more source